Latest Breaking News On - Immunologie de marseille luminy - Page 2 : vimarsana.com

<p style="text-align:justify"><strong>Infections with cytomegalovirus (CMV) are extremely common and often pose no major threat to the vast majority of people. They can however be deadly for people whose immune system is weakened, e.g., after bone marrow transplantation. Current treatments against CMV infections are very limited and can have severe side effects. Researchers led by Prof. Michael Sieweke at the Center for Regenerative Therapies Dresden (CRTD) at TUD Dresden University of Technology and the Center of Immunology of Marseille Luminy (CIML) propose a new way to protect against CMV. Instead of targeting the virus, their approach boosts the weak immune system and lets it fight the virus on its own. The results were published in the journal <em>EMBO Molecular Medicine</em>.</strong></p>

Noushin mossadegh kellerCaroline huberPrashanthk kandallaMartin bornhPrashanth kumar kandallaJohanna iaconoMarc dalodMarseille immunopoleMarseille luminyGilles bessouMichaelh siewekeRolandp bouretteSelena tomaselloJulien subburayaluMarseille universitWilfried cathou